Abstract: A relay node for a radio access network, arranged to be a relay node between one or more User Equipments in a cell of the radio access network and a base station serving the cell. The relay node is arranged to identify itself as a relay node in the cell in the radio access network, and is also arranged to receive a non-support indication indicating that the base station serving the cell is unable to support a relay node. The relay node is arranged to, upon receiving said non-support indication, attempt to establish itself as a relay node in another cell.

Abstract: The invention provides a method and a network node for controlling configuration of measurements to be performed by a user equipment (150a, 150b) operating in a wireless communication system (101). A configured measurement corresponds to at least one reporting criteria and the user equipment (150a, 150b) is able to support a limited number of parallel reporting criteria. Measurements to be performed by the user equipment in parallel may be requested by different network nodes such as a positioning server (140) and an eNodeB (110a, 110b). By letting a network node, such as the positioning server (140) or the (eNodeB 110a, 110b), obtain information on measurements requested by another network node the network node is able to configure the user equipment with a set of measurements that does not exceed at least one predetermined threshold for parallel reporting criteria.

Abstract: The invention relates to a transdermal therapeutic system which comprises a backing layer, an adhesive layer, a polymer layer and a removable protective layer. The adhesive layer is an organosiloxane layer and is anchored in the backing layer by siliconization.

Abstract: The invention relates to a method for radio-link monitoring in a user equipment (4) of a communication network (1). The user equipment (4) receives and/or sends on a first carrier using a primary radio access technology system (2) and on a second carrier using a secondary radio access technology system (3). The method comprises: receiving (100), from a network node (5), information about the primary radio access technology system (2) and the secondary radio access technology system (3), and determining (110), in dependence on information related to the primary radio access technology system (2) and the secondary radio access technology system (3), whether to monitor radio link criteria on: the first carrier on the primary radio access technology system (2), or both the first carrier on the radio access technology system (2) and the second carrier on the secondary radio access technology system (3). The invention also relates to a user equipment implementing the method.

Abstract: A method for setting a mobile communication terminal of a cellular communication network in an idle mode. The method is performed in a network node and comprises the steps of starting a first inactivity timer; starting a second inactivity timer; resetting the first inactivity timer when control signalling associated with the mobile communication terminal is detected; resetting the second inactivity timer when payload data associated with the mobile communication terminal is detected; and setting the mobile communication terminal in an idle mode when both the first inactivity timer and the second inactivity timer have expired. A corresponding network node is also presented.

Abstract: Methods, nodes, computer programs, computer program products and a mobile network for adapting a mobile network are described. In such a method for adapting a mobile network (800), a terminal (802) is connected to a first access node (804) of the mobile network (800) via a first connection and to a second access node (808) via a second connection. The first access node (804) controls a data transmission for the terminal (802) and the second access node (808) assists in the data transmission for the terminal (802). The method comprises determining (7) whether a quality of at least one of the first connection and the second connection is degraded, acquiring (7) quality degradation information about the degradation of the quality of at least one of the first connection and the second connection based on the step of determining, and adapting (896, 8, 898, 899, 10, 11) the mobile network (800) based on the step of acquiring.

Abstract: The present disclosure concerns movements, such as handovers, of user equipments (UEs) 120a-e from one radio cell 130a to another radio cell 130b. Disclosed herein are methods as well radio network nodes 110a, 110b. A radio network node 110a, 110b may, for example, select the most suitable UE(s) 20a-e to move from a source radio cell 130a to a target radio cell 130b in case the traffic load in the source radio cell 130a is below or equal to the traffic load of the target radio cell 130b. Hereby it is made possible to improve the resource utilization.

Abstract: Systems and methods relating to reconfiguration of a Carrier Aggregation (CA) enabled wireless device using a measurement gap are disclosed. In some embodiments, a method of operation of a CA enabled wireless device in a cellular communications network comprises reconfiguring the wireless device during a measurement gap such that the wireless device is enabled to receive a first set of one or more carriers after the measurement gap that are different than a second set of one or more carriers that the wireless device was receiving before the measurement gap. In some embodiments, the reconfiguration of the wireless device during the measurement gap enables reconfiguration of the wireless device for measurements on a Secondary Component Carrier (SCC) of a configured and deactivated Secondary Cell (SCell) of the wireless device without serving cell interruption.

Abstract: Transdermal or topical plasters containing active ingredient are provided that include a non-occlusive back layer, a matrix formed from of one or more polymer layers having at least one pharmaceutical active ingredient in one or more of the layers, in which the structure-forming base polymers of the layer(s) are non-occlusive or only slightly occlusive and a second polymer that has a low water-vapor permeability and that is immiscible or only very slightly miscible with the base polymer is dispersed in at least one of the polymer layers.

Abstract: According to one aspect of the teachings herein, a wireless device operating in a wireless communication network determines the difference in signal arrival times with respect to first and second cells, and the device and/or the involved wireless communication network uses the difference to control one or more aspects of Carrier Aggregation, CA, operation for the wireless device. For example, there may be a maximum timing difference defined for the wireless device, e.g., as a function of its inherent capabilities, and the wireless device may evaluate the timing difference of a second cell that is a candidate of aggregation into its CA configuration, or that may be a candidate for activation as a serving cell within a CA configuration, with respect to a first cell that is already in use as a serving cell for the wireless device.

Abstract: Methods and operations in mobile terminals and base stations are disclosed which control uplink signaling. A method in a mobile terminal controls uplink signaling to a base station, and includes receiving a MAC CE from the base station. The MAC CE indicates whether at least one of SRS or CQI reports should be transmitted for one or more serving cells configured for the mobile terminal. Transmission of at least one of the SRS or the CQI reports for the one or more serving cells from the mobile terminal to the base station is selectively activated and deactivated responsive to the MAC CE. Related methods and operations by base stations and mobile terminals are disclosed.

Abstract: The present invention relates to a transdermal therapeutic system, comprising (a) a backing layer, (b) a solvent-based self-adhesive matrix layer containing rotigotine as active ingredient, and (c) a release liner, wherein the self-adhesive matrix layer has a coating weight of about 75-400 g/m2 and comprises a reservoir layer containing about 9-25 wt.-% rotigotine based on the weight of the reservoir layer, a kit comprising two transdermal therapeutic systems of the present invention as well as a method for the preparation of the transdermal therapeutic system of the present invention.

Abstract: A wireless terminal (30) capable of operating in a discontinuous mode and method for operation facilitate measurements pertaining to position of the wireless terminal (30). A measurement request message from a radio access network (28) indicates that measurements are to be performed by the wireless terminal on downlink signals transmitted by the base station or by the base station on downlink signals transmitted by the base station. As a result of or after receiving the message, operation of the wireless terminal (30) changes from a discontinuous mode to a modified mode to facilitate performance of the measurements. Relative to the discontinuous mode at least one of following are shortened or eliminated in the modified mode: (i) the non-reception periods, and (ii) the non-transmission periods.

Abstract: Measurement handling is of interest in a user equipment (UE) in connected mode, with the UE being configured with multiple downlink component carriers (CCs). The UE evaluates the signal quality of a specific CC of the configured CCs against a configurable threshold to determine the need for neighbor cell measurements. The UE performs neighbor cell measurements if the signal quality of the specific CC is below the configurable threshold. In this way, robust and efficient measurement handling is provided, even though the UE is configured with multiple component carriers.

Abstract: The present invention relates to methods and arrangements for handling unreliable scheduling grants in a WCDMA-communication system. A user equipment detects that a received scheduling grant is unreliable and adjust its serving grant based on that information. The user equipment is also able to report continuously received unreliable grants as an event to the network, allowing the network to adapt its operation to reduce the unreliable grants.

Abstract: The invention provides a method and a network node for controlling configuration of measurements to be performed by a user equipment (150a, 150b) operating in a wireless communication system (101). A configured measurement corresponds to at least one reporting criteria and the user equipment (150a, 150b) is able to support a limited number of parallel reporting criteria. Measurements to be performed by the user equipment in parallel may be requested by different network nodes such as a positioning server (140) and an eNodeB (110a, 110b). By letting a network node, such as the positioning server (140) or the (eNodeB 110a, 110b), obtain information on measurements requested by another network node the network node is able to configure the user equipment with a set of measurements that does not exceed at least one predetermined threshold for parallel reporting criteria.

Abstract: A transdermal therapeutic system for administering at least one active pharmaceutical ingredient, including a polymer layer which is remote from the skin and is based on polyisobutylenes with a rate of application of at least 80 g/m2, and an adhesive skin-contact layer which is adjacent to the polymer layer remote from the skin and is based on acrylate copolymers with a rate of application of not more than 50 g/m2. The at least one active pharmaceutical ingredient is present in both the layer remote from the skin and the skin-contact layer.

Abstract: An indication of the speed of movement of a UE in a radio communications system is received at a network node of the radio communications system. The parameters of the radio communications system are then analyzed using the speed of movement indication. The system parameters are then adjusted using the analysis.

Abstract: The invention relates to a transdermal therapeutic system which comprises a back layer that is impermeable to the active substance, and a peelable protective layer that is impermeable to the active substance and at least one matrix layer consisting of polysiloxanes and/or polysiloxane derivatives and containing micro-reservoirs. Said micro-reservoirs contain at least one ion pair from a pharmacologically active substance and an additive and either the active substance is nucleophilic and the additive is electrophilic or the active substance is electrophilic and the additive is nucleophilic.

Abstract: The invention relates to a diecasting die, in particular in a diecasting hot-runner system, wherein the diecasting die is provided in a feeding region for forming a plug of solidified molten material that interrupts a flow of the molten material and can be completely remelted. A diecasting die is provided according to the preamble of the invention that is suitable for different molten materials, in which a heating acts directly on the molten material with high power and largely without delay. Cooling is not required and the injection-molding method can be carried out at a high operating machine speed and under feeding conditions that can be monitored and reproduced well. A feeding region is provided comprising direct resistance heating that produces a melting heat and is in direct thermal contact with the molten material.